Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00230685

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

Hammersmith Hospital Patients With Pulmonary Arteriovenous Malformations (PAVMs) and Hereditary Haemorrhagic Telangiectasia

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.

Detailed description

The Hammersmith Hospital provides a clinical service for patients with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that is unique in the United Kingdom. Measurements obtained as part of standard clinical practice that has evolved since 1985 allow us to assess whether particular groups of individuals that we see are more prone to recognised complications such as strokes, brain abscesses, pregnancy related complications or pulmonary hypertension. We hypothesise that certain clinical characteristics will predict the susceptibility of individuals to particular complications.

Conditions

Timeline

Start date
2000-01-01
Primary completion
2028-01-01
Completion
2028-01-01
First posted
2005-10-03
Last updated
2023-09-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00230685. Inclusion in this directory is not an endorsement.